Global expert services and consulting firm Berkeley Research Group (BRG) has announced that former Food and Drug Administration (FDA) Chief Counsel Dan Troy has joined the firm's Washington, D.C. office as a managing director in its Health Analytics practice. His pharmaceutical and regulatory expertise will bolster the practice's ability to address FDA issues on behalf of its clients.
Dan Troy, managing director of Berkeley Research Group. Courtesy photo
A globally recognized health care lawyer, Troy has practiced at the highest levels of the pharmaceutical sector. He served as chief counsel at the FDA and spent a decade as general counsel and senior vice president of GSK plc. Dan was previously a partner at preeminent law firms Sidley Austin LLP and Wiley Rein LLP, where he advised multinational health care companies. At BRG, Troy will work with law firms and pharmaceutical companies to provide expert witness testimony on FDA regulatory and related matters.
